Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
about
Enhanced nasal mucosal delivery and immunogenicity of anti-caries DNA vaccine through incorporation of anionic liposomes in chitosan/DNA complexesMolecular adjuvant interleukin-33 enhances the antifertility effect of Lagurus lagurus zona pellucida 3 DNA vaccine administered by the mucosal routeAntitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems.Enhanced immune response and protective effects of nano-chitosan-based DNA vaccine encoding T cell epitopes of Esat-6 and FL against Mycobacterium tuberculosis infection.Carbohydrate-based immune adjuvants.In vivo distribution of surface-modified PLGA nanoparticles following intravaginal deliveryTechnologies for enhanced efficacy of DNA vaccines.Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein.Nanoparticles as protein and gene carriers to mucosal surfaces.Chitosan-based systems for the delivery of vaccine antigens.Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles.Progress towards a needle-free hepatitis B vaccine.Advances in effective vaccine development against hepatitis B: focus on mucosal vaccine delivery strategies.Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective.Chitosan-based vaccine adjuvants: incomplete characterization complicates preclinical and clinical evaluation.Nanocarriers in therapy of infectious and inflammatory diseases.Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery.Dry-powder form of chitosan nanospheres containing influenza virus and adjuvants for nasal immunization.DNA-loaded chitosan oligosaccharide nanoparticles with enhanced permeability across Calu-3 cells.Recent developments in nanocarrier-aided mucosal vaccination.Conjugating influenza a (H1N1) antigen to n-trimethylaminoethylmethacrylate chitosan nanoparticles improves the immunogenicity of the antigen after nasal administration.Comparison on in vitro characterization of fucospheres and chitosan microspheres encapsulated plasmid DNA (pGM-CSF): formulation design and release characteristics.Application of quality by design approach to optimize process and formulation parameters of rizatriptan loaded chitosan nanoparticles.EphA2-derived peptide vaccine with amphiphilic poly(gamma-glutamic acid) nanoparticles elicits an anti-tumor effect against mouse liver tumor.Chitosan-plasmid nanoparticle formulations for IM and SC delivery of recombinant FGF-2 and PDGF-BB or generation of antibodies.Self-Assembled Hydrogel Nanoparticles for Drug Delivery Applications.Nanoparticle Vaccines Against Infectious DiseasesCharacterization of Plasmid DNA Location within Chitosan/PLGA/pDNA Nanoparticle Complexes Designed for Gene Delivery
P2860
Q27309096-246E221A-5C00-4A3F-B586-910D9B14A643Q28658606-158DF24F-1A03-4841-BBFB-FE66DD34FBFBQ34544509-F40F583A-F53D-49D5-A355-FEEF88C5D49BQ34700107-1F8244F9-CDBB-4F2A-B908-4F413CE2338EQ35054845-EEF99990-0544-48CA-9DB8-AB2C9D9A2723Q35563449-945FF977-2EC4-4975-A055-4CE1119AADA7Q35802958-77158213-230F-462C-BC4A-CA3DF22074A5Q35878909-6C8CD7AC-5708-4DFB-945F-FF3C9A94D841Q37331802-D5A0324E-DCAC-4F4F-AF62-9F55033AA9DBQ37524050-1E577FDD-43DD-4351-92D2-727038727017Q37766235-A1FDC706-4E4B-46A2-B862-207D4279DF09Q37810816-BB5574A3-56F3-49F8-A45D-EAF41D4D78C8Q38027857-605E1E87-D494-4B7A-B2B8-FC683BB97A9EQ38066148-080242D9-B6C8-4943-9F43-A6E8B60F6641Q38254989-71C1F5EB-F1FD-469B-95BB-A2A2D9B64CDCQ38354723-2201380B-8A43-407A-AD54-03AA000D7C75Q38879581-1789294B-C0AB-4F8E-9474-FD9AFC5691F0Q39169219-E0BF3E66-D9BD-40EE-8CB2-A8ABE36C38DCQ39182355-98CA6510-A293-4C13-A77B-008EE2C4448CQ40228907-AF9010F1-5279-4A70-980B-ECBADB1697D9Q41244310-1958D4AC-D40B-4AAE-A80D-BAFC6B93B2AAQ41989091-48D35DA4-C79C-4CF4-BEBF-D71CF3750B41Q42682506-C1B29D97-7A94-4C39-9AE7-BD2CAF2C27F6Q43234771-3643C8C8-1B9C-43D2-8771-654F2CA95F66Q45885233-B6C8886F-8C6F-4F43-AB69-750676ACE91EQ47098115-7F779F04-CDEC-4DDD-B9D1-7CC089558313Q58583890-1C46940B-EC3E-44DE-9CDF-C67C9949C8ACQ58691248-E8E9D610-7DDF-42F0-8F09-1625B1D3328F
P2860
Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Plasmid DNA loaded chitosan na ...... unization against hepatitis B.
@en
Plasmid DNA loaded chitosan na ...... unization against hepatitis B.
@nl
type
label
Plasmid DNA loaded chitosan na ...... unization against hepatitis B.
@en
Plasmid DNA loaded chitosan na ...... unization against hepatitis B.
@nl
prefLabel
Plasmid DNA loaded chitosan na ...... unization against hepatitis B.
@en
Plasmid DNA loaded chitosan na ...... unization against hepatitis B.
@nl
P2093
P1476
Plasmid DNA loaded chitosan na ...... unization against hepatitis B.
@en
P2093
Amit K Goyal
Kapil Khatri
Neeraj Mishra
Prem N Gupta
Suresh P Vyas
P304
P356
10.1016/J.IJPHARM.2007.11.027
P407
P577
2007-11-22T00:00:00Z